Paper30525762
Sarcopenia associated with chemotherapy and targeted agents for cancer therapy.
Davis MP and 1 other. Ann Palliat Med, 2019. Cited by 133 papers, by iCite.
Cite this record
ConductScience Library. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Papers, record 30525762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30525762
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Sarcopenia | Major topic |
| Absorptiometry, Photon | |
| Androgen Receptor Antagonists | |
| Appetite Stimulants | |
| Combined Modality Therapy | |
| Dietary Proteins | |
| Fatty Acids, Omega-3 | |
| Ghrelin | |
| Humans | |
| Molecular Targeted Therapy | |
| Muscular Diseases | |
| Obesity | |
| Resistance Training | |
| Testosterone | |
| Tomography, X-Ray Computed | |
| Treatment Outcome | |
| Vitamin D |
Source PubMed
Cited by88
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959917 | Impact of body composition on toxicity and response in patients with advanced-stage Hodgkin lymphoma treated with BV-AVD. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/42959917 | PubMed |
| 42866359 | Assessment of chemotherapy-associated sarcopenia using SARC-F and handgrip strength: a cross-sectional analysis. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42866359 | PubMed |
| 42845809 | Effects of exercise training on cardiotoxicity in cancer survivors. A systematic review. | F1000Res | 2022 | https://conductscience.org/library/papers/42845809 | PubMed |
| 42761662 | Therapy-induced immunoediting and the evolution of cancer immune escape. | Front Immunol | 2026 | https://conductscience.org/library/papers/42761662 | PubMed |
| 42512393 | Persistent Chemotherapy-Induced Peripheral Neuropathy as a Chronic Cancer Pain Syndrome: Mechanisms, Therapeutic Limitations, and Future Directions. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512393 | PubMed |
| 42370358 | Association between pre-treatment malnutrition and chemotherapy toxicity in patients with advanced or metastatic gastroenteric tumors receiving systemic therapy. | Front Nutr | 2026 | https://conductscience.org/library/papers/42370358 | PubMed |
| 42049416 | Bioelectrical Impedance Analysis in the Diagnosis of Sarcopenia in Oncological Patients: The Sarco-Detect Study. | In Vivo | 2026 | https://conductscience.org/library/papers/42049416 | PubMed |
| 41881664 | Nutritional pathways from treatment to management of sarcopenia in patients with gastric cancer: a narrative review. | Korean J Fam Med | 2026 | https://conductscience.org/library/papers/41881664 | PubMed |
| 41873816 | Skeletal Muscle Loss During Neoadjuvant Chemotherapy for Breast Cancer: Diabetes as an Independent Predictor. | Eur J Breast Health | 2026 | https://conductscience.org/library/papers/41873816 | PubMed |
| 41869452 | Impact of Skeletal Muscle-related Parameters on Survival in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine plus Nab-paclitaxel as First-line Chemotherapy. | J Cancer | 2026 | https://conductscience.org/library/papers/41869452 | PubMed |
| 41857153 | Prognostic impact of sarcopenia and blood biomarkers in advanced non-small cell lung cancer on first-line immune checkpoint inhibitors. | Sci Rep | 2026 | https://conductscience.org/library/papers/41857153 | PubMed |
| 41568365 | Effect of short-term oral nutrients after hospital discharge on postoperative muscle loss and survival in gastric cancer patients. | Front Oncol | 2025 | https://conductscience.org/library/papers/41568365 | PubMed |
| 41551865 | Temporal muscle measurements as predictor for outcome in a cohort of IDH-wildtype glioblastoma patients. | Brain Spine | 2026 | https://conductscience.org/library/papers/41551865 | PubMed |
| 41339473 | A transformer-based prognostic signature integrating tumor and body composition CT images predicts postoperative recurrence in gastric cancer. | NPJ Digit Med | 2025 | https://conductscience.org/library/papers/41339473 | PubMed |
| 41258980 | Current Status and Influencing Factors of Postoperative Sarcopenia in Pancreatic Cancer Patients. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41258980 | PubMed |
| 41081183 | Role of muscle glucometabolism derived from 18F-FDG PET/CT in sarcopenia of elderly patients with newly diagnosed malignancies. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/41081183 | PubMed |
| 40947050 | TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder Breast Cancer Patients (THRIVE 65). | Contemp Clin Trials | 2025 | https://conductscience.org/library/papers/40947050 | PubMed |
| 40832641 | Comparative assessment of sarcopenia screening tools for patients with bone tumors: insights for enhanced clinical application. | Front Nutr | 2025 | https://conductscience.org/library/papers/40832641 | PubMed |
| 40760116 | Body components at T12/L3 on CT and correlation with survival in esophageal cancer. | Eur Radiol | 2026 | https://conductscience.org/library/papers/40760116 | PubMed |
| 40757547 | Sarcopenia and Pleural Mesothelioma: The Current Knowledge. | Muscles | 2024 | https://conductscience.org/library/papers/40757547 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30525762
GET https://conductscience.org/api/papers/v1/30525762/cited_by?page=2